首页> 外文会议>第二届全国分子模拟与信息技术软件应用研讨会暨第四届创腾科技用户大会 >Structure-based design and characterization of a Novel IL-6 antagonist peptide
【24h】

Structure-based design and characterization of a Novel IL-6 antagonist peptide

机译:一种新型IL-6拮抗剂肽的基于结构的设计和表征

获取原文

摘要

The development of rational methods to design antagonist peptides based on the 3-D structure of protein active region has, to now, been only marginally successful. This has been largely due to the difficulty of constraining the recognition elements of a mimetic structure to the relative conformational and spatial orientations present in the parent molecule. According to the 3-D complex structure of human interleukin-6 (hIL-6) and its receptor (hIL-6R), a novel antagonist peptide (named PT), which possessed potential bioactivity of hIL-6, was designed by the means of distance geometry, molecular modeling and molecular dynamics trajectory analysis. The bioactivity of the designed peptide (i.e. PT) was evaluated using XG-7 cells, a hIL-6-dependent B-cell line. PT possessed potential bioactivity to antagonize the function of hIL-6 and could efficiently induce the growth arrest and apoptosis of XG-7 cells in a dose-dependent manner.
机译:基于蛋白质活性区域的3d结构的拮抗剂肽设计拮抗剂肽的理性方法的发展已经仅略微成功。这主要是由于难以将模拟结构的识别元件限制为母体分子中存在的相对构象和空间取向。根据人白细胞介素-6(HIL-6)及其受体(HIL-6R)的三维复合结构,通过手段设计了具有HIL-6的潜在生物活性的新型拮抗剂肽(命名为Pt)距离几何,分子建模与分子动力学轨迹分析。使用XG-7细胞,依赖于依赖于HIL-6依赖性B细胞评估设计肽(即Pt)的生物活性。 PT具有潜在的生物活性来拮抗HIL-6的功能,并且可以以剂量依赖性方式有效地诱导XG-7细胞的生长停滞和凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号